Join Johnson & Johnson virtually for the live broadcast of their flagship data science event in Basel (Switzerland) on what it will take for AI to move from hype to embedded impact in pharma R&D. Together with leaders from Johnson & Johnson and the European innovation ecosystem, we will explore which Digital, Data Science & AI capabilities are likely to create durable value in drug discovery and development, including frontier models for biology, digital health and AI biomarkers, GenAI for scientific reasoning, and agentic technologies that can support R&D workflows.
The event is designed for startups, scale-ups, academic innovators, investors and ecosystem partners interested in building AI capabilities that are differentiated, scalable and relevant to real R&D needs.